MNTA’s poison pill and the standstill agreement with NVS were two distinct entities, but both expired in 2008. There are currently no legal impediments to an acquisition of MNTA by NVS or another suitor.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”